Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2025 07:00 ET | Source: BPGbio

BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease

New findings challenge the longstanding assumption that postmortem tissue accurately represents the living brain and creates new frontier for drug research
August 19, 2025 08:54 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

60 Degrees Pharma selects Mount Sinai as central site for Phase II tafenoquine trial in chronic babesiosis; enrollment starts Q4 2025, data 2026.
January 10, 2022 06:30 ET | Source: Cullinan Oncology, Inc.

Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment

Collaboration to identify and advance best-in-class HPK1 protein degraders Exclusive option for Cullinan to license related intellectual property from the collaboration CAMBRIDGE, Mass., Jan. ...
September 09, 2020 09:00 ET | Source: LymeMIND

LymeMIND, a division of the Icahn School of Medicine at Mount Sinai, to Host LymeMIND 2020 Virtual Conference on October 10

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- LymeMIND, the data coordination center of the Cohen Lyme & Tickborne Disease Initiative, housed at the Icahn School of Medicine at Mount Sinai, today...
September 18, 2019 08:15 ET | Source: Institute for Next Generation Healthcare

Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai Announces Upcoming LymeMIND Conference: Lyme Disease in the Era of Precision Medicine

NEW YORK, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai today announced that it will be hosting its fourth...
May 22, 2019 09:08 ET | Source: MediPharm Labs Corp.

New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction

TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
May 13, 2019 12:14 ET | Source: Institute for Next Generation Healthcare

The Institute for Next Generation Healthcare Opens Lyme Disease Experience Booth to the Public at Mount Sinai Hospital

The fully-immersive booth will be available to former and existing Lyme disease patients, caregivers, researchers, and clinicians for three weeks, providing a platform to share their stories during...
September 18, 2018 14:00 ET | Source: bioAffinity Technologies, Inc.

Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung

SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
September 04, 2018 08:00 ET | Source: Institute for Next Generation Healthcare

Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai Announces Upcoming LymeMIND Conference on Lyme Disease and Precision Medicine

NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- The Institute for Next Generation Healthcare (INGH) at the Icahn School of Medicine at Mount Sinai today announced that it will be hosting its third...
November 01, 2016 08:00 ET | Source: biotricity

Renowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of Advisors

REDWOOD CITY, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- biotricity, Inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...